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Executive Summary

Hypertension is prevalent worldwide and is responsible for nine million deaths annually.
Despite its prevalence, a majority of patients go unmanaged or undiagnosed (Kitt et al., 2019).
Health complications of hypertension can be life-altering and life-threatening; therefore, if
changes are not made to improve community hypertension control rates, worsened population
health and financial burden on health systems may persist. Would you believe that an effective
tool exists and has been endorsed worldwide to combat hypertension, yet it is not used
consistently in practice? Furthermore, can you imagine this specific tool is easy to operate,
cheap, and recruits patient involvement in their care? This tool is home blood pressure
monitoring (HBPM), and it has the potential to improve blood pressure control.
In caring for patients with hypertension and other cardiovascular diseases for over five
years, it is astounding to realize how many patients that are treated for hypertension do not have
a blood pressure monitor at home. This realization sparked interest in creating an evidence-based
project that utilizes home blood pressure monitoring to improve blood pressure control. A project
for change has been created based on the following PICOT question: In adult patients diagnosed
with hypertension (P), how does home blood pressure monitoring (I) compared to no blood
pressure monitoring (C) affect blood pressure (O) twelve weeks after diagnosis (T)?
This project outlines that patients will participate in HBPM each morning for a twelveweek (3 month) period. Patients will follow up at one-week, four-week, and twelve-week
intervals either by telehealth visit or in clinic visit to ensure close monitoring and safety. To
evaluate the outcomes of the intervention blood pressure readings will be calculated to determine
a change in blood pressure readings and evaluate blood pressure control rates over twelve weeks.
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Home Blood Pressure Monitoring
Rationale for the Project

Hypertension is a health condition that is widely known within health care and in the
public. Despite public knowledge and effective treatment options that are readily available,
hypertension control rates are suboptimal (Zalloum et al., 2015). Health complications of
hypertension can be life-altering and life-threatening. Furthermore, hypertension-related
morbidity and mortality place a significant financial burden on health systems and society (Mills
et al., 2016). These factors make hypertension management an important topic in the realm of
improving population health.
Each clinical diagnosis of hypertension is unique, which can be challenging for the
provider to effectively manage the disease. Equally as challenging, providers can be misguided
in diagnosing or treating hypertension based on the single blood pressure that is measured in the
clinic setting. A variety of factors can cause changes in blood pressure measurements that are
taken at the time of evaluation. This can result in unnecessary medical therapy or negative health
outcomes.
HBPM goes beyond what is seen in the clinic setting and extends a greater understanding
of the overall health of the patient by revealing day to day variances in the patient’s blood
pressure. This can make blood pressure management more efficient and individualized to
achieve optimal blood pressure control. Incorporating home blood pressure monitoring into the
usual care of patients with hypertension is a more reliable method that has the potential to
improve community hypertension control rates, improve population health, and decrease
financial burden on health systems.
Literature Synthesis
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A literature search was conducted by using four databases: Academic Search Complete,
CINAHL Complete, Health Source: Nursing/Academic Edition, and PubMed. The search was
limited by applying the search terms “blood pressure AND hypertension AND home
monitoring”. Further limitations included peer reviewed articles, full text, and dated between
April of 2014 and September of 2020. Related words and equivalent subjects were also applied
to the search. Twelve articles of varied levels of evidence were identified that provided
overwhelming evidence to support the use of HBPM in the management of hypertension.
The most substantive evidence to support this project illustrates that HBPM contributes to
effective blood pressure control when compared to clinic blood pressure monitoring (Cairns et
al., 2018; Chmiel et al., 2014; Pan et al., 2018; Qi et al., 2017). The studies showed a significant
change in blood pressure between the intervention group (HBPM) and control group over
different periods of time. Cairns et al. (2018) and Chmiel et al. (2014) conducted their study over
six months; whereas, Pan et al. (2018) studied patients up to 12 months, and Qi et al. (2017)
conducted their study over five years. The literature also supports that HBPM is a simple costeffective intervention that improves blood pressure control and encourages patient involvement
in care management (Chmiel et al., 2014; Qi et al., 2017; Zalloum et al., 2015). Since
compliance and acceptance by patients can be a barrier to evidence-based interventions,
choosing an intervention that recruits patient involvement is more likely to ensure successful
implementation.
Sharman et al. (2016) established a quick method for interpreting HBPM that revealed
having three or more of the last ten home systolic blood pressure readings greater than 135
mmHg was a predictor for uncontrolled hypertension. This study determined that this method of
HBPM allowed providers to identify patients at risk for target organ disease and intervene sooner

BLOOD PRESSURE

7

to reduce morbidity and mortality related to hypertension (Sharman et al., 2016). A crosssectional correlation study by Zalloum et al. (2015) found that patients with hypertension who
performed HBPM more frequently had significantly reduced blood pressure readings.
Additionally, patients who performed HBPM had better compliance with their medications and
reported healthier lifestyle habits such as decreased salt intake and exercise (Breaux-Shropshire,
2015; Zalloum et al., 2015). Three qualitative interview studies conducted by Bradbury et al.
(2018) that found that patients viewed HBPM to be easy, beneficial, and empowering in the
management of hypertension, and one mixed method study by Cairns et al. (2020) found that
patients perceived a better sense of control over their health with HBPM.
Project Stakeholders
Identifying stakeholders is essential to gain support, reduce barriers, and understand
critical perspectives when implementing and evidence-based intervention. For this HBPM
project, the following stakeholders have been identified: patients with hypertension and their
families, organization administration, the cardiology clinic manager, doctors, nurse practitioners,
physician assistants, and nursing staff. Patients with hypertension and their families are
considered the most important stakeholders for this project. Without gaining support from the
patients, implementation will fail, because patients will be carrying out the intervention.
Organizational administration and the cardiology clinic managers are essential stakeholders
because approval for the project and project funds will have to be obtained for the intervention to
be implemented. Additionally, doctors, nurse practitioners, physician assistants, and nursing staff
providing care for patients with hypertension are important stakeholders because they can
provide unique perspectives of suitable patients, safety considerations, and realistic expectations
for the intervention and evaluation of project goals.
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Planned Implementation

The successful implementation of an evidenced-based change project requires a thorough
and well-prepared plan. The following plan is broken down by specific steps of the project that
fit into each week through implementation. This should be followed step by step to ensure
success with future implementation.
Week One
Step One: Approval
During week one, implementation planning will begin by gaining approval for the project
from organizational leadership officials, the cardiology clinic manager, and participating
providers. A formal meeting with a presentation of data that highlights the prevalence, morbidity,
and mortality rates of hypertension in the community will be presented. Financial burden of
hypertension on the institution, such as hypertension-related emergency room visits,
hospitalizations, and long-term health complications, will be discussed. Approval for project
funds must also be obtained.
Step Two: Team Recruitment
Also, during week one, the project team will be recruited. Four cardiology providers, two
medical office assistants, two nurses, one information technologist, and one electronic health
record specialist from the cardiology clinic will be needed. Realistic expectations will be
provided on the role, responsibility, and length of the project to assist in recruiting team
members that will commit to complete the project in its entirety.
Week Two
Step Three: Assignment of Team Roles
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During week two, the project team will meet to discuss role responsibilities of each team
member. The team will be provided with a presentation of the project plan, timeline, goals, and
outcomes. During this meeting, collaboration by all members will allow for skill gaps to be
discussed and filled. If skill gaps are identified that cannot be filled by current team members,
recruitment of additional specialists is encouraged.
Step Four: Patient Recruitment
Also, during week two, patients will be recruited by providers in the cardiology clinic to
participate in the project. For this piloted project, 30 adult patients with hypertension should be
recruited to participate in HBPM. Patients must give informed consent to participate and agree to
monitor their blood pressure daily for twelve weeks. At recruitment, background and contact
information should be verified to assist with follow up. It should also be determined whether
patients have their own blood pressure monitor or if one will need to be provided.
Week Three
Step Four: Patient Recruitment (Continued)
Week three will allow for an additional week of recruitment so that the project team is
able to ensure the appropriate number of participants for the study. The recruitment process for
week three will be the same as described for the previous week.
Week Four
Step Five: Patient Education
During week four, patients will be scheduled to attend educational sessions where
patients are taught how to properly use their blood pressure monitor for the implementation
phase of the project. Blood pressure monitors will be distributed for patients who do not have a
home monitor. For patients wishing to use their own home monitor, devices must be confirmed
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as a validated device intended to use on the upper arm. Blood pressure cuffs will be approved for
proper fit for each individual. Standardized blood pressure logs will be provided at this visit to
each participant. An example of a similar blood pressure log is located in Appendix C. Baseline
blood pressures will be established the same day as the educational sessions with the same
monitor that the patient will be using at home. Patients will be provided with instructions for
HBPM which include the following information:
•

Perform HBPM in the morning before taking medications

•

Use the same arm every day to monitor blood pressure readings

•

Take the blood pressure reading after five minutes of being seated and with legs
uncrossed

•

Take two readings at least two minutes apart

•

The second reading should be recorded

Week Five to Seventeen
Step Six: Implementation
Implementation of HBPM begins the Monday after educational sessions are completed.
Patients will monitor their blood pressures daily for twelve weeks. Clinic staff, including medical
office assistants, nurses, and providers should be prepared to answer or return calls promptly to
assist patients through the first week of monitoring if questions are to arise. On the day of project
implementation, clinic nurses will schedule participants follow up appointments and determine
their preference for follow up, in clinic or via telehealth.
Step Seven: Follow Up
Follow up appointments will be scheduled for patients at one week, four weeks, and
twelve weeks after implementation. Blood pressure logs will be reviewed, and data will be
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transcribed at each follow up appointment, either by direct transcription during in-clinic follow
up appointments or transcribed from the patient portal for telehealth follow up appointments.
Each follow up appointment should address patient perceptions, concerns, or needs. At the
twelve-week follow up appointment, final blood pressure readings should be obtained and
reviewed for completion.
Timetable/Flowchart
On August 24, 2020, a project proposal meeting will be held with organizational
administration, the cardiology clinic manager, and other organization officials to gain approval
for the project. Recruitment of project team members will occur during August 25 through
August 28. Team roles will be assigned and a formal education session for team members will be
held on August 31. Patient recruitment by providers will occur during a two-week period
between September 1 and September 11. Educational sessions with patients will be held in the
morning for about an hour and a half from September 14 to September 18, and baseline blood
pressures will be established during these sessions. Implementation of HBPM will begin on
September 21 and continue through the last follow up appointment held on December 14. Follow
up appointments will be held on September 28, October 19, and December 14. Evaluation and
interpretation of the HBPM data will be conducted between December 14 and December 18. A
meeting to debrief with the project team will be held on December 18. A presentation will be
created by volunteers from the project team will be allowed during the week of December 21
through December 27. On December 28, 2020 outcomes of the project will be disseminated to all
stakeholders through a formal presentation.
The flow of events depicts the suggested timeline of this benchmark study. Dates are
provided to give future direction for the project to be replicated with a different population.
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HBPM and the evaluation of outcomes for this project has a linear flow due to the simplicity of
the intervention and the outcomes to be evaluated; therefore, there is little overlapping or
simultaneous processes being evaluated. This is reflective in the flowchart and the dates
provided. The flowchart for the project is located in Appendix B.
Data Collection and Planned Evaluation
Initially, education sessions will be scheduled for all 30 patients the week prior to
implementation. Baseline blood pressures will be established on the day of education sessions,
and this blood pressure data will be used to compare future readings throughout follow up.
Patients will be provided with a standardized blood pressure log to document their readings. The
implementation phase begins with patients monitoring their blood pressure at home, and this will
be continued for a total of twelve weeks. Patients will be required to follow up after
implementation at specific intervals: one week, four weeks, and twelve weeks. Blood pressure
data will be obtained at each follow up appointment either by direct transcription of blood
pressure logs for those who choose to attend follow up by traditional clinic visits or by
transcribing readings that are uploaded into the online patient portal for those choosing telehealth
follow up appointments.
At the designated follow up appointment one week after implementing HBPM, nursing
staff will be responsible for transcribing each patient’s blood pressure values of day one through
day seven into a database. This process will be the same for the four-week and twelve-week
follow up appointment in which nursing staff will transcribe blood pressure data for each patient
of days eight through 28 and days 29 through the completion day of the project, respectively.
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After the implementation phase is complete and all data is obtained, blood pressure data
will be verified for completeness and the data will be evaluated to determine if outcome goals are
met.
The two primary goals for this project that gauge the project for success include:
1. Have 25 of the 30 participants complete the project entirely (83.3%).
2. Have 15 patients achieve blood pressure control by the end of the three-month
period (50%).
After a review of the data, it will be determined how many patients completed the project
entirely by manually counting how many participants had at least one blood pressure reading
documented in the logbook for every day throughout the intervention period. Blood pressure
readings for each patient will be calculated to determine each patient’s mean systolic and
diastolic blood pressure at one week, four weeks, and twelve weeks after implementation using
the data within the follow up period described previously. Data will also be calculated to
determine the percentage of patients that achieved or maintained blood pressure control after the
three-month period of applying HBPM. Blood pressure control will be determined by greater
than fifty percent of blood pressure readings less than 140/90. This will be conducted by
identifying the number of patients with an average blood pressure for the 12-week follow up
period less than 140/90 and dividing it by the number of patients that participated in the study.
This will reveal the percentage of patients achieving blood pressure control. If at least 50 percent
of patients achieve blood pressure control and at least 25 patients complete the study entirely,
then the intervention will be successful.
Cost/Benefit Discussion
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Cost consideration is an important component of an evidence-based intervention project.
Calculating the cost to plan, implement, and evaluate the project, as well as determining fees for
services provided by the project team, is essential to gain support for the project by
administration and determine if the investment is worth the expenditure for the organization. For
this HBPM project, costs are minimal due to the simplicity of the intervention; therefore, a
majority of the costs will be spent on staffing educational sessions, follow-up visits, and
evaluation processes.
The following hourly rates will be used to estimate staff costs for training and services
provided for the project: providers ($150/hour), nurses ($25/hour), medical office assistant
($15/hour), information technologist (IT) ($20/hour), and electronic health record (EHR)
specialist ($20/hour). Four physicians, two nurses, two medical office assistants, one IT
personnel, and one EHR specialist will be needed. For the planned two-hour staff training
education session, costs include: $1,200 for providers, $100 for nurses, $60 for medical office
assistants, $40 for the IT, and $40 for the EHR specialist for an approximate total of $1,440. To
provide nursing staff for the planned patient education sessions for five days that will last one
and a half hours each day, it will cost $375. Provider costs for the scheduled follow up
appointments for each patient (15-minute sessions for three follow up visits) will cost
approximately $3,375. Additional funding to have nursing staff assistance to transcribe blood
pressure log data into the database for all three follow up appointments will cost approximately
$960. Standardized blood pressure logs will need to be printed and provided for each of the 30
patients, and this is estimated to cost approximately $100. A blood pressure fund of $1,000 will
allow for blood pressure monitors to be provided for all 30 patients. Some patients may have
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their own monitor that they wish to use; therefore, the entire fund may not be used. For this
project, the total funding needed to support this HBPM project is approximately $7,250.
According to a study by Kirkland et al. (2020), annual healthcare expenditure costs for
one patient with hypertension is approximately $1,920 compared to patients without
hypertension. Since the goal for this project is to have 50 percent of patients achieve blood
pressure control with the use of HBPM, if 15 patients do achieve blood pressure control then
HBPM has the potential to save the organization $28,800 in just one year. If the total cost of the
project is approximately $7,250 and the potential savings for organization is approximately
$28,800, the net savings for the institution is $21,550 annually for only 15 patients achieving and
maintaining blood pressure control.
Discussion of Results
Although this project is presented in the form of a benchmark project, support for future
implementation has been expressed by multiple providers and staff within the current
organization. This important to ensure successful implementation in the future. At the end of the
implementation period, patients’ blood pressures will be evaluated for change over time. For this
project to be deemed successful, at least 25 patients must complete the project entirely and at
least 15 patients must obtain blood pressure control. These specific goals have been set to
improve the health of the targeted project population and offload some financial burden on the
institution related to hypertension. Goals for this project are set with very realistic measures for a
piloted HBPM project; therefore, it is suspected that these goals will be obtained when the
project is implemented. It is also suspected that institution and participant costs, as well as
adverse outcomes related to the project, will be minimal.
Conclusions/Recommendations
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In creating a benchmark HBPM project that was not actually conducted, it is important to
make plans for implementation and consider future directions of the project. The next step is to
move toward actual implementation. As preparations are made to implement this benchmark
project, it is important to partner with an organization that supports evidence-based practice and
has a quality improvement framework to ensure sustainment of the HBPM intervention (Kumar
et al., 2015). Considering new technological innovations to assist in delivery and evaluation of
outcomes is another important component to consider with future implementation. For example,
using a blood pressure monitor that can directly upload patient data to the electronic health
record patient portal could reduce errors in transcribing data and result in more accurate
evaluation of data. Additionally, expansion of the HBPM intervention to a larger population of
patients is ideal to provide a larger impact on population health and relieve hypertension-related
financial burdens on the healthcare system.
If for some reason, the HBPM intervention were not approved by organizational
leadership, formal education with providers on the importance of HBPM or proposing the
establishment of a hypertension clinic could improve patient outcomes could encourage the use
of HBPM in the management of hypertension without having a formal project. As a future nurse
practitioner, it is recommended that HBPM be used in the management of all patients with
hypertension that are physically and mentally able to perform the task based on the
overwhelming evidence that already exists. It is recommended that the facility develop a protocol
for HBPM patient education to be presented annually for all patients with hypertension.
Colleagues, patients, and leadership are encouraged to communicate the importance of
hypertension management throughout the community to encourage patients and future patients to
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seek routine health exams and hypertension screening to reduce hypertension-related morbidity
and mortality. These strategies encourage a healthier population for generations to come.
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Appendix A

PICOT Question: In adult patients diagnosed with hypertension (P), how does home blood pressure monitoring (I) compared with
no blood pressure monitoring (C) affect blood pressure (O) twelve weeks after diagnosis (T)?
PICOT Question Type (Circle): Intervention Etiology
Citation:
(i.e.,
author(s),
date of
publication,
& title)
Author,
Year, Title

Conceptual
Framework
Theoretical
basis for
study
Qualitative
Tradition

Design/
Method

Sample/ Setting
Number,
Characteristics,
Attrition rate &
why?

Major
Variables
Studied and
Their
Definitions
Independent
variables
(e.g., IV1 =
IV2 =)
Dependent
variables
(e.g., DV = )

Diagnosis or Diagnostic Test Prognosis/Prediction Meaning

Measurement of
Major Variables
What scales were
used to measure
the outcome
variables (e.g.,
name of scale,
author, reliability
info [e.g.,
Cronbach
alphas])

Data
Analysis
What stats
were used
to answer
the clinical
question
(i.e., all
stats do not
need to be
put into the
table)

Study Findings
Statistical findings or
qualitative findings (i.e.,
for every statistical test
you have in the data
analysis column, you
should have a finding)

Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
• Strengths and limitations of the study
• Risk or harm if study intervention or
findings implemented
• Feasibility of use in your practice
• Remember: level of evidence (See Melnyk
& Finout-Overholt, pp. 32-33) + quality of
evidence = strength of evidence & confidence
to act
• Use the USPSTF grading schema
http://www.ahrq.gov/clinic/3rduspstf/ratings.
htm
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Appendix A (continued)

Qi, Qiu, &
Zhang, 2017,
Home blood
pressure
monitoring is
a useful
measurement
for patients
with
hypertension:
A long-term
follow-up
study.

None
stated

Double-blind
RCT

n= 1183
CG: n= 596
SOG: n= 587
Recruited at
community
hypertension
management
center
Characteristics:
-Sex: M (SOG:
290, CG: 499);
F (SOG: 243,
CG: 223)
-Age: (SOG:
63.5 ± 11.4,
CG: 64.5 ±
10.2)
-DM: (SOG:
23%, CG:
32%)
-Smoking:
(SOG: 32%,
CG: 34%)
-BMI: (SOG:
28.1 ± 3.4, CG:
27.5 ± 3.7)
-CHOL:
(SOG: 6.1 ±
0.7, CG: 5.9 ±
0.6)
Attrition:
relocation
(SOG: 24, CG:
14), refusal
follow-up
(SOG: 22, CG:
76), death
(SOG: 10, CG:
7)

IV: HBPM vs
CBPM
DV1: BP
control
DV2:
adherence

Validated and
approved
automated BP
device for SOG
BP recorded
within 1 hour of
awakening and
after seated for 5
minutes

Mean (SD)

Percentages
(%)

SBP ↓ for SOG: 4.3 (± 3.2)
SBP ↓ for CG: 3.9 (± 3.1)
DBP ↓ for SOG: 3.5 (±
2.5)
DBP ↓ for CG: 3.0 (± 2.5)
Improved at goal BP:
SOG: 85.37%
CG: 79.96%

Strengths: HBPM endorsed by international
guidelines, ↑ patient engagement, cost-effective,
simple intervention, extended follow-up period
Limitations: patient adherence to intervention,
attrition
Risk/harm: lack of BP control and development
of complications
Feasibility: feasible for use in current and future
practice

Two-tailed ttest

SBP and DBP for SOG
and CG: p < 0.05

Level of Evidence: RCT- Level 2
USPSTF: Grade: B; Level of certainty:
Moderate
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Sharman,
Blizzard,
Kosmala, &
Nelson,
2016,
Pragmatic
method using
blood
pressure
diaries to
assess blood
pressure
control.

None
stated

RCT

n = 286
Recruited
through general
practice clinics
and community
advertisement
in Australia
Characteristics:
-Age: 64 (8)
-Sex (F): 53%
-BMI: 29.4
(4.8)
-CBP: [SBP:
134 (14), DBP:
78 (10)]
-24h ABP:
[SBP: 133 (12),
DBP: 77 (8)]
-7d HBP:
[SBP: 128 (13),
DBP: 74 (8)]
Measurement
of TOD:
-AS: 9.4 (2.1)
-LVRWT: 0.47
(0.20)
-LVMI: 31.3
(5.5)
-LVEF: 62 (5)
-LAA: 20.4
(4.2)
-LVFP: 11.6
(3.6)
Attrition:
Not discussed

IV: HBPM vs
CBP
DV: BP
control, AS,
LVRWT,
LVMI, LVEF,
LAA, EVFP

CBP: automated
oscillometiric BP
device (HEM-907;
OMRON Europe
BV) after seated
for 5 minutes
7d HBP: BP
device (UA767,
A&D Mercury),
duplicate
measurements, 1
min apart, only
recording the
second level,
3x/day, after
seated for 5
minutes, apply
usual guidelines
for BP
24h ABP: BP
device (TM-2430,
A&D Mercury),
measurements
every 30 min 6A10P, every 60 min
10P-6A
AS: tomometric
carotid-to-femoral
pulse wave
velocity
(SphygmoCor 8.0,
AtCor Medical)
LVMI & LVEF:
real-time 3D
echocardiography
LVFP: pulsedwave Doppler.

Mean (SD)

Percentages
(%)

Last 10 readings with < 3
elevations:
• ABP daytime SBP:
132.7 (± 11.1)
• HBP SBP: 120.4 (±
9.8)
Last 10 readings with ≥ 3
elevations:
• ABP daytime SBP:
143.4 (± 11.2)
• HBP SBP: 147.4(±
10.5)
Controlled HBP (<135mm
Hg):34%
Controlled daytime ABP
(<135mm Hg): 44%

Sensitivity

(≥ 3 cut point):
Mean 24h ABP SBP ≥
130: 62.1%
Mean 24h ABP daytime
SBP ≥ 130: 64.6%

Specificity:

(≥ 3 cut point):
Mean 24h ABP SBP ≥
130: 80.2%
Mean 24h ABP daytime
SBP ≥ 130: 77.2%

Strengths: HBPM widely used, ↑ patient
adherence to therapy, standardized method for
HBPM
Limitations: ↓ sample size, patient error in
recording BP, not applicable to patients with BP
> 180/100
Risk/harm: lack of BP control and development
of target organ disease
Feasibility: feasible for use in current and future
practice
Level of Evidence: RCT- Level 2
USPSTF: Grade: B; Level of certainty:
Moderate
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Bradbury,
Morton,
Band, van
Woezik,
Grist,
McManus,…
Yardley,
2018, Using
the PersonBased
Approach to
optimize a
digital
intervention
for the
management
of
hypertension.

None
stated

Qualitative
interview
study

n = 30
Recruited from
Primary Care
practices in
South England
Characteristics:
-Age (median):
S1 (69)
S2 (69)
S3 (65)
-Sex (F):
S1 (6)
S2 (7)
S3 (3)
-Yr since
diagnosis
(median):
S1 (8)
S2 (20)
S3 (10)
-Ethnicity
(WB):
S1 (11)
S2 (10)
S3 (7)
-Employment
(retired):
S1 (9)
S2 (7)
S3 (5)
Attrition:
Not discussed

IV: HBPM vs
CBP
DV: patients’
perceptions of
HBPM

HOME BP digital
intervention,
Band, Morton,
Stuart, Raftery,
Bradbury,…
McManus (2016)

Qualitative
data

Interview
questions

Study 1 & 2:
• HOME BP benefit:
-Control over health
-Pleased to learn correct
method of HBPM
-Eliminates wait for
physical appointment
-More accurate readings
than CBP
• HOME BP concern:
- ↓ quality of service for
med changes
-impersonal
Study 3:
• HOME BP concern:
-No consideration for
factors that affect BP
-Security risk for
sending online info
-Distrust in online
provider
Patients in all studies:
general belief that HBPM
is empowering, easy,
beneficial.

Iterative
analysis

-BP instructions made
clearer, repeated
-Explained BP varies
naturally
-Changed BP procedure to
1 wk of practice
-Added diet sodium
information
-Added BP cuff
information
-Reinforced that provider
would adjust meds, not
website
-Changed information to
state that HOME BP Is
secure

Strengths: direct quotations from patient
perspective, ↑ patient engagement, easy
intervention
Limitations: ↓ sample size, ↓ information
regarding pt experience with medication
changes, ↓ participants in study 3, ↓ variation in
ethnic representation, requires computer literacy
Risk/harm: lack of BP control and development
of complications
Feasibility: feasible for use in current and future
practice
Level of Evidence: Qualitative Study- Level 6
USPSTF: Grade B; Level of certainty: Low
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Zalloum,
Farha,
Ruqa’a,
Khdair, &
Basheti,
2015, Blood
pressure
home
monitoring in
hypertensive
patients
attending a
tertiary
health
facility in
Amman,
Jordan:
Effect on
disease
control and
adherence
rate.

None
stated

Crosssectional
correlation
study

n = 205
Recruited from
cardiovascular
clinics at
Jordan
University
Hospital

IV: HBPM vs
CBP
DV: adherence
to BP meds,
BP control

Questionnaire

Mean (SD)

Stringent protocol
in data collection
to reduce bias by
researchers
Percentages
(%)

Characteristics:
-Age: 50-69
years: 59%
-Sex(F): 52.7%
-Employed:
30%
-Retired: 34%
-Bachelor’s
degree: 32.2%
-Diagnosis 1020 yrs: 37.1%
Attrition: not
discussed

-HBPM: 15.5 (± 7.83)
times/month
-Low BP: 4.1 (± 1.04)
times/month
-High BP: 3.1 (± 1.2)
times/month
-Don’t forget BP meds:
69.3%
-Don’t stop BP meds for
any reason: 89.4%
-Stopped BP meds for side
effects: 25.7%
-↑ salt intake for low BP:
52.8%
-↓ salt intake for high BP:
75.6%
-Doctor or ER visit for BP:
54.8%

Spearman’s
correlation
(r)

-Older age and use of air
meter/mercury meter:
(r = 0.239, p = 0.001)
-↑ frequency of BP reading
and stabilized BP:
(r = - 0.232, p = 0.002)

Logistic
Regression
Analysis

-Association with
adherence to medication:
• Education level
(higher): (p = 0.044)
• BP readings (low): (p =
0.002)

Strengths: popular method, intervention
accepted by patients and providers, ↓ observer
bias, ↓ white coat effect, inexpensive
intervention
Limitations: role of pharmacist was not
investigated, socioeconomic factors not
discussed, methodology not sufficient to draw
clear conclusions
Risk/harm: lack of BP control and development
of complications
Feasibility: Feasible for use in current and future
practice
Level of Evidence: Descriptive Study- Level 6
USPSTF: Grade: B; Level of Certainty:
Moderate
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Chmiel,
Senn,
Rosemann,
Del Prete, &
Steurer-Stey,
2014, CoCo
trial: Colorcoded blood
pressure
control, a
randomized
controlled
study.

None
stated

RCT

n = 121
Recruited by
GPs in Zurich
and St. Gallen,
Switzerland.
Characteristics:
-Age:
[IG: 61.5
(±13.1), CG:
62 (±12.6)]
-Sex (M):
[IG: 53.9%,
CG: 44.6%]
-BMI:
[IG: 28.2
(±4.3), CG:
28.8 (±5.4)]
-Smokers:
[IG: 21.5%,
CG: 23.2%]
-# of BP meds:
[IG: 1.3 (±0.9),
CG: 1.6 (±1.0)]
-SBP:
[IG: 157
(±15.3), CG:
159.5 (±13.2)]
-DBP:
[IG: 91.8
(±7.6), CG:
92.8 (±9.6)]
Attrition:
-Not met
inclusion
criteria: (IG: 3,
CG: 8)
-Not met
exclusion
criteria: (IG: 2,
CG: 3)

IV1: CoCo
HBPM vs
Standard
HBPM
DV: patients’
perceptions of
HBPM

Automated
electronic
oscillometric BP
device (MioStar
Cardioplus 500)
was used for CBP
and HBPMvalidated for
accuracy by EUM
norm (EN1060).

Mean (SD)

Percentages

Cuff sizes were
chosen by GPs to
fit each patient
individually.

-SBP after 6 months: [IG:
141.4 (±13.0), CG: 146.4
(±17.9)]
-DBP after 6 months: [IG:
83.8(±9.8), CG: 84.2
(±11.7)
-BP control: (IG: 43.1%,
CG: 25%)
-HBPM adherence: (IG:
98.6%, CG: 96.2%)
-BP med changed after 6
months: (IG: 59.7%, CG:
68.1%)

Strengths: randomized controlled study, ↑
patient decision-making, ↑ patient health
strategies, BP improvement without medication
changes, simple intervention
Limitations: ↓ sample size, lack of blinding, ↓
patient-GP interaction, no evening or daytime
measurements
Risk/harm: lack of BP control and development
of complications
Feasibility: Feasible for use in current and future
practice
Level of Evidence: RCT- Level 2

Patient BP
instructions:
• every AM before
meds
• seated
• after resting for
5 minutes
• left upper arm
with arm resting
on table

Multi-level
regression
analysis

-Reduced SBP for IG:
(regression coefficient 4.26, 95% CI -7.85, -0.68;
p = 0.020)
-Reduced DBP for IG:
(regression coefficient 1.03, 95% CI -4.22, 2.15; p
= 0.53

USPSTF: Grade: B; Level of certainty:
Moderate
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Cairns,
Tucker,
Leeson,
Mackillop,
Santos,
Velardo,
Salvi, Mort,
Mollison,
Tarassenko, &
McManus,
2018, Selfmanagement
of postnatal
hypertension:
The SNAPHT trial.

None
stated

RCT

n = 82
Recruited from
five National
Health Service
hospital sites in
England
Characteristics:
-Age:
[IG: 31.7 (±5.3),
CG: 31.7 (±5.3)]
-Mean BMI:
[IG: 29.0 (±7.5),
CG: 28.0 (±8.3)]
-Parity:
0: (IG: 32 CG: 31)
³1: (IG: 13 CG:
15)
-Median
Gestation at
Diagnosis:
[IG: 35.9), CG:
34.7]

IV1: HBPM
vs CBP
DV:
Feasibility,
BP control

Validated BP
device was used
for HBPM
(Microlife
WatchBP Home)

Mean (SD)

The same BP
device was used
for follow-up
visits.
Cuff sizes were
determined by arm
circumference
measurement.

Percentages

Attrition:
-Withdrew during
follow up (IG: 5,
CG: 4)
Adjusted
Mean
Differences
(95% CI)

-SBP after 6 weeks: [IG:
121.6 (8.7), CG: 126.6
(±11.0)]
-DBP after 6 weeks: [IG: 80.5
(±6.6), CG: 86.0 (±9.7)]
-SBP after 6 months: [IG:
125.8 (±12.9), CG: 126.8
(±14.0)]
-SBP after 6 months: [IG:
81.0 (±8.2), CG: 85.5 (±9.9)]

Strengths: ↑ patient decision-making, simple
intervention, adequate follow-up visits and
length of follow up, limited detection bias by
using a validated BP monitor, convenient
follow-up visits at home.

-Retention rate at 6 weeks:
(IG: 89%, CG: 91%)
-Retention rate at 6 months:
(IG: 91%, CG: 94%)
-F/U visits attended by
population that finished F/U
(98%)
Mean of readings 2 & 3
-BP in target range at F/U (6
weeks): (IG: 93%, CG: 62%)
-BP in target range at F/U (6
months): (IG: 80%, CG: 62%)
Mean of readings 2-6
-BP in target range at F/U (6
weeks): (IG: 88%, CG: 60%)
-BP in target range at F/U (6
months): (IG: 75%, CG: 67%)

Risk/harm: lack of BP control and
development of complications

-SBP after 6 weeks: -5.2
(-9.3 to -1.2)
-DBP after 6 weeks: -5.8
(-9.1 to -2.5)
-SBP after 6 months: -1.0
(-6.3 to 4.4)
-SBP after 6 months: -4.5
(-8.1 to -0.8)

Limitations: ↓ sample size, lack of blinding, ↓
diversity in ethnicity and socioeconomic
status of participants, trial was not powered to
detect a difference in secondary outcomes

Feasibility: Feasible for use in current and
future practice
Level of Evidence: RCT- Level 2
USPSTF: Grade: B; Level of certainty:
Moderate
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de Heus,
Tumelaire,
Olde Rikkert,
& Claassen,
2019,
Diagnostic
accuracy of
office blood
pressure
compared to
home blood
pressure in
patients with
mild cognitive
impairment
and dementia.

None
stated

Crosssectional
study

n = 213
Recruited from a
memory clinic at a
university teaching
hospital between 2014
and 2017.
Characteristics:
-Age:
DEM group: 77.3 (7.4)
MCI group: 74.4 (8.0)
CN group: 67.5 (8.8)
-Sex (F):
DEM group: 45.1 (37)
MCI group: 43.1 (28)
CN group: 36.4 (24)
- # of Drugs:
DEM group: 4 (2–7)
MCI group: 4 (1–7)
CN group: 5 (1- 8)
-Use of BP meds:
DEM group: 61.0 (50)
MCI group: 56.9 (37)
CN group: 56.1 (37)
- History of CV
disease:
DEM group: 46.3 (38)
MCI group: 43.1 (28)
CN group: 56.1 (37)
Attrition:
-Did not meet the
minimum number of
twelve BP readings: 25
–No CBP level for
comparison: 23

IV1: HBPM
vs CBP
DV:
Misdiagnosis
of HTN

Validated,
memory
equipped,
automatic BP
device was used
for HBPM
(Microlife
WatchBP Home)
Demonstration
and written
instruction for
HBPM were
provided.
Duplicate
morning (6A10A) and evening
(5P-9P)
measurements for
7 days.
BP readings
taken while
sitting for 5
minutes with arm
supported by
table.

Mean (SD)

Mean home SBP compared to
CBP: -16.8
Mean home DBP compared
to CBP: -5.0

Strengths: validated BP device, ↑ patient
involvement, simple intervention, large age
diversity, evaluated patients with varied
cognitive function.

Percentages

Disagreement in hypertension
diagnosis between HBPM and
CBP:
Total sample: 31%
DEM group: 35.4%
MCI group: 38.5%
CN group: 18.2%

Limitations: possible bias due to variations in
cognition, cannot ensure adherence to BP
instructions, lacks long-term follow up.

Adjusted
Odds Ratio

Disagreement in hypertension
diagnosis:
MCI group: 3.7
DEM group: 3.4
WCH:
MCI group: 5.1
DEM group: 2.9

Risk/harm: lack of BP control and
development of complications
Feasibility: Feasible for use in current and
future practice
Level of Evidence: Descriptive Study- Level
5
USPSTF: Grade: B; Level of certainty:
Moderate
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Pan, Wu, Liu,
Zhang, Peng,
Wei, & Gao,
2018, Effects
of home
telemonitoring
on the control
of high blood
pressure: A
randomised
control trial in
the
Fangzhuang
Community
Health Center,
Beijing.

None
stated

RCT

n = 110
Recruited from a
Fangzhuang
Community Health
Center
Characteristics:
-Age:
[IG: 56.55 (±9.8),
CG: 57.8 (±10.87)]
-Sex (M):
[IG: 26, CG: 24]
-BMI:
[IG: 25.25 (±3.45),
CG: 25.78 (±3.07)]
-Smokers:
[IG: 11.5%, CG:
15.4%]
-# of BP meds:
[IG: 1.68 (± 0.55),
CG: 1.89 (±0.53)]
-SBP:
[IG: 148 (±7.1), CG:
147.9 (±8.7)]
-DBP:
[IG: 88.0 (±7.5), CG:
87.0 (±8.4)]
Attrition: Two
patients from the IG
moved out of the
community, and one
patient from the IG
withdrew from the
study

IV1: Home BP
telemonitoring
vs CBP
DV: BP control

Automated BP
device which
uploaded BP
levels to a
hypertension
management
platform by a
smart phone
application.
The same BP
device was used
for clinic visits
also.
Training sessions
were provided on
HBPM with BP
device and app.

Mean

Reduction in SBP:
- Day 30: (IG: 14.2, CG: 6.2)
- Day 90: (IG: 16.1, CG: 9.2)
- Day 180: (IG: 16.4, CG: 9.8)
Reduction in DBP:
- Day 30: (IG: 5.4, CG: 5.6)
- Day 90: (IG: 9.5, CG: 6.1)
- Day 180: (IG: 7.4, CG: 4.4)

Chi squared
(χ²)

Control Rate of BP
Day 30: 9.98
Day 90: 8.68
Day 180: 4.67

Strengths: ↑ patient awareness, adequate
length of follow up, remote monitoring
extends services beyond clinic physical
boundaries, better accessibility and
continuity of care.
Limitations: ↓ sample size, lack of blinding,
long term health outcomes not assessed, trial
was not designed to assess risk of CV
disease, adverse psychological effects were
not measured
Risk/harm: lack of BP control and
development of complications
Feasibility: Feasible for use in current and
future practice

Percentages
(%)

Pearson’s r

Control Rate of BP
Day 30: (IG: 71.2, CG: 40.0)
Day 90: (IG: 67.3, CG: 38.5)
Day 180: (IG: 63.6, CG: 41.8)
Correlation between reduction
in blood pressure and use of
app for IG (r = 0.302, P =
0.029).

Level of Evidence: RCT- Level 2
USPSTF: Grade: B; Level of certainty:
Moderate
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BreauxShropshire,
Judd,
Vucovich,
Shropshire, &
Singh, 2015,
Does home
blood pressure
monitoring
improve
patient
outcomes? A
systematic
review
comparing
home and
ambulatory
blood pressure
monitoring on
blood pressure
control and
patient
outcomes.

None
stated

Systematic
review

n = 19
Literature search
performed using these
databases: PubMed,
CINAHL (EBSCO),
Scopus, &Cochrane
Central (Wiley) using a
variety of search terms
modified for each
database. Two reviewers
independently reviewed
each article.
Characteristics:
-Study type:
Observational: 9
Quasi-experimental: 5
RCT: 5
-Sample size range:
Observational: 210 to
2,051
Quasi-experimental: 53 to
121
RCT: 51 to 426
-Median follow up:
Observational: 0 to 10.9
years
Quasi-experimental: 0 to
12 weeks
RCT: 0.5 to 12 weeks
-Study Location:
United States: 3
Belgium: 1
Japan: 3
Italy: 4
Spain: 2
Australia: 1
Brazil: 2
Switzerland: 1
Finland: 1
Germany: 1
Attrition: none

IV1:
HBPM vs
Ambulatory
BP
DV: BP
control,
patient
outcomes

Jaded scale was
used to assess
research
methodology and
scientific merit of
RCTs (assigned
numeric score 1 to
5).
Newcastle-Ottawa
scale was used to
assess
observational
studies.

Qualitative
synthesis

HBPM is as good or better
than ABP monitoring for
prediction of mortality for
patients ≥ 60.
Using HBPM to target
antihypertensive treatment
resulted in better BP
control for patients
receiving hemodialysis.
Using HBPM to titrate BP
medication produces same
level of control as ABP.
CBPM has lower
sensitivity to detect
optimal BP control defined
by HBPM and ABP.
Correlation between
HBPM and ABP is
stronger than CBPM with
ABP.

Strengths: comparison of multiple studies
with similar findings, intervention
encourages patient involvement,
intervention encouraged medication
adherence and adoption of healthy lifestyle
habits.
Limitations: small sample size,
malalignment of studies and systematic
reviewers’ interpretation of BP control,
variability of length of monitoring and
frequency of measurement,
Risk/harm: lack of BP control and
development of complications
Feasibility: Feasible for use in current and
future practice
Level of Evidence: Systematic reviewLevel 1
USPSTF: Grade: C; Level of certainty:
Moderate
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Cairns,
Tucker,
Crawford,
McManus,
Powell,
2020,
Implementin
g selfmanagement
: A mixed
methods
study of
women's
experiences
of a
postpartum
hypertension
intervention
(SNAP-HT).

None
stated

Mixed
methods
study

n = 68
Recruited from five
National Health
Service hospital sites
in England during
pregnancy.
Interviews took place
after delivery.
Characteristics:
-Age:
[IG: 32.5 (±5.0), CG:
31.9 (±4.8)]
-Mean BMI:
[IG: 28.8 (±8.1), CG:
28.5 (±9.0)]
-Parity:
0: (IG: 22 CG: 22)
³1: (IG: 12 CG: 12)
-Median Gestation
at Diagnosis:
(IG: 36.1, CG: 34.9)
Attrition: Failure to
complete second
interview
(IG: 2, CG: 8).

IV1: HBPM vs
CBPM
DV: patients’
perceptions

Semi-structured
interviews
provided
reproducible
format for
consistency.

Qualitative
analysis

Likert scale (1-5)
was used for
patient responses
to standardized
questions in both
groups.

• Control
-IG: ↑ control, ↑ responsibility
-CG: variable responses
regarding control, responsibility,
and med adjustment
• Convenience
-IG: variable responses on
access to care, ↑ relationship
with provider
-CG: variable responses on
access to care, difficulty making
appointments, ↑ relationship
with provider
• Confidence, Communication, &
Knowledge
-IG: ↑ confidence in
communicating with provider,
knowledge of BP readings was
helpful
-CG: variable responses
regarding communication with
providers and provider
knowledge
• Concern
-IG: HBPM ↓ anxiety

Mean (SD)

IG only questions:
-Fit with condition: [4weeks:
4.8(0.4), 6 months: 4.8 (0.5)]
-Ease/Difficulty of use: [4weeks:
4.9(0.3), 6 months: 4.9 (0.4)]
-Change in lifestyle: [4weeks:
4.1(0.9), 6 months: 4.4 (0.9)]
-Likely to recommend: [4weeks:
4.9(0.3), 6 months: 4.9 (0.4)]
-Likely to continue: [4weeks:
4.1(0.9), 6 months: 4.4 (0.9)]

Adjusted
Difference
Between
Groups

4 weeks: 0.6 (95% CI 0.2 to 1.1)
6 weeks: 0.7(95% CI 0.3 to 1.2)

Strengths: ↑ patient involvement, adequate
length of follow up, ↑ patient control in BP
management, single reviewer for
qualitative analysis of interviews,
quantitative component.
Limitations: potential for bias because all
who interviewed were enrolled in RCT,
lack of independent researchers (members
of the trial team conducted interviews),
English language only for interview
Risk/harm: lack of BP control and
development of complications
Feasibility: Feasible for use in current and
future practice
Level of Evidence: Mixed-Methods studyLevel 5
USPSTF: Grade: C; Level of certainty:
Moderate
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Aekplakorn,
Suriyawongp
aisal,
Tansirisithik
ul,
Sakulpipat,
&
Charoensuk,
2016,
Effectivenes
s of selfmonitoring
blood
pressure in
primary care:
A
randomized
controlled
trial.

None
stated

RCT

n = 224
Recruited from a
community hospital
registry for patients
living in Bang phli
district, Sautprakarn
providence
Characteristics:
-Age:
[IG: 58(±9.4), CG:
60.83 (±9.0)]
-Sex (M):
[IG: 39, CG: 39]
-BMI:
[IG: 27.3 (±5.2), CG:
26.4 (±4.5)]
-Smokers:
[IG: 5.4%, CG:
12.4%]
-# of BP meds:
1: (IG: 32, CG: 39)
2: (IG: 51, CG: 52)
≥ 3: (IG: 28, CG: 22)
-SBP:
[IG: 149.4 (±11.4),
CG: 147.2 (±14.9)]
-DBP:
[IG: 83.4 (±9.9), CG:
82.2 (±11.7)]
Attrition: At six
months, one patient
from the IG and one
patient from the CG
withdrew.

IV1: HBPM vs
CBPM
DV: BP control

Automated BP
device (Omron
model HEM7117).
Japanese Society
of Hypertension
guideline 2003:
BP measured
twice dailymorning and
evening (three
readings obtained
each time).
Each patient was
instructed
individually
about how to use
the monitor,
record, and
interpret the BP
data.

Mean

Mean
Difference

SBP at 6 months: (IG: 137.4,
CG: 137.9)
DBP at 6 months: (IG: 76.4, CG:
76.0)
SBP at 12 months: (IG: 136.4,
CG: 136.8)
DBP at 12 months: (IG: 78.1,
CG: 78.1)
6 months: (SBP: -2.9, DBP: -0.6)
12 months: (SPB: -2.5, DBP-1.2)

Strengths: ↑ patient awareness and
compliance to medications, adequate
length of follow up, rules out WCH.
Limitations: ↓ sample size, lack of
blinding, low percentage of complete BP
records, details of meds at follow up not
provided.
Risk/harm: lack of BP control and
development of complications
Feasibility: Feasible for use in current and
future practice

Percentages
(%)

Uncontrolled BP
was defined by
SBP ≥ 140 mm
Hg or DBP ≥ 90.
Difference
Between
Groups (p
value)

Uncontrolled BP:
All:
-Baseline (IG: 97, CG: 88)
-6 Months (IG: 41, CG: 43)
-12 Months (IG: 51, CG: 52)
<60:
-Baseline (IG: 47, CG: 34)
-6 Months (IG: 17, CG: 15)
-12 Months (IG: 30, CG: 18)
≥60:
-Baseline (IG: 50, CG: 54)
-6 Months (IG: 24, CG: 28)
-12 Months (IG: 21, CG: 36)
All:
Baseline to 6 Months: 0.13
Baseline to 12 Months: 0.13
<60:
Baseline to 6 Months: 0.28
Baseline to 12 Months: 0.78
≥60:
Baseline to 6 Months: 0.24
Baseline to 12 Months: 0.02

Level of Evidence: RCT- Level 2
USPSTF: Grade: B; Level of certainty:
Moderate
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Appendix A (continued)

Spirk, Noll,
Burnier,
Rimoldi, Noll,
& Sudano,
2018, Effect
of home blood
pressure
monitoring on
patient's
awareness and
goal
attainment
under
antihypertensi
ve therapy:
The factors
influencing
results in antihypertensive
treatment
(FIRST)
study.

None
stated

Cohort
study

n = 1, 268
30 to 36 physicians
from each of the 10
sectors in
Switzerland were
randomly chosen
from a registry to
enroll up to 5 patients
in the study.
Characteristics:
-Age: 61.2 ± 12.5
-Sex (F): 48.6%
-BMI: 28.4 ±5.0
-Diabetes: 18.8%
-SBP: 161.5 ± 17.1
-DBP: 95.7 ± 10.8
- HBPM: 59.8%
Attrition: 117 did not
show up for follow
up appointment at 3
months

IV1: HBPM vs
CBPM
DV: patients’
awareness, BP
control

Automated BP
device (Microlife
3AC1-1PC,
Average Mode)
BP levels were
automatically
stored on the
device for
physician review.
Detailed training
sessions were
provided on
HBPM and
documentation.
HBPM was
performed once
weekly and on
the 6 consecutive
days prior to each
physician visit.
BP taken after
resting for 5
minutes, before
drug intake, in a
quiet room,
seated, and after
> 30 minutes
without smoking,
caffeine, meal, or
exercise.

Percentages
(%)

Mean (SD)

BP Goal Attainment after 3
months:
- HBPM: 64%
- CBPM only: 57%

Strengths: large sample size, ↑ patient
awareness, ↑ patient involvement, simple
intervention, cost-effective, automated BP
device with storage.

Patient awareness of BP goals:
- HBPM: 81%
-CBPM only: 70%

Limitations: observational, short follow up
period, lack of blinding and randomization,
no exclusion criteria, medication therapy
used alongside HBPM.

SBP:
- HBMP: 138 ± 13
- CBPM only: 139 ± 14
DBP:
- HBMP: 83 ± 9
- CBPM only: 84 ± 9
Reduction in SBP between
groups:
- Total: 23.8
- Irbesartan 300mg + HCTZ
12.5mg: 26.4

Risk/harm: lack of BP control and
development of complications
Feasibility: Feasible for use in current and
future practice
Level of Evidence: Cohort study- Level 4
USPSTF: Grade: B; Level of certainty:
Moderate

Reduction in DBP between
groups:
- Total: 13.2
- Irbesartan 300mg + HCTZ
12.5mg: 13.3

Legend: RCT: randomized controlled trial, SOG: self-observation group, CG: control group, IG: intervention group, DM: diabetes
mellitus, CHOL: serum cholesterol, IV: independent variable, HBPM: home blood pressure monitoring, CBPM: clinic blood pressure
monitoring, DV: dependent variable, BP: blood pressure, CBP: clinic blood pressure, SBP: systolic blood pressure, DBP: diastolic BP,
HBP: home blood pressure, ABP: ambulatory blood pressure, TOD: target organ disease, AS: aortic stiffness, LVRWT: left
ventricular relative wall thickness, LVMI: left ventricular mass index, LVEF: left ventricular ejection fraction, LAA: left atrial area,
LVFP: left ventricular filling pressure, WB: White British, HOME BP: Home and online management and evaluation of hypertension,
HTN: hypertension, CoCo: Color-coded, GPs: general practitioners, AM: morning, F/U: follow-up, HTN: hypertension, CV:
cardiovascular, DEM: dementia, MCI: mild cognitive impairment, CN: cognitively normal, WCH: white coat hypertension
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Appendix B

Aug 24, 2020 Project
proposal meeting

Oct 19, 2020
Follow up (4 weeks)

Dec 14, 2020 Follow
up (12 weeks)

Aug 25-28, 2020
Project team
recriutment

Sept 28, 2020
Follow up (1 week)

Dec 14-18, 2020
Data Interpretation/
Evaluation of
Outcomes

Aug 31, 2020
Assignment of roles
& team education

Sept 21, 2020
Implementation of
HBPM

Dec 18, 2020
Debrief with team

Sept 1-11, 2020
Patient recruitment

Sept 14-18, 2020
Patient education
sessions & baseline
BP established

Dec 21-27, 2020
Team Creation of
Presentation

Dec 28, 2020
Outcomes
presented to
stakeholders
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Appendix C: Instrument

Home Blood Pressure Log

Use this logbook to document your blood pressure readings

Systolic
Day 1
Day 2
Day 3
Day 4
Day 5
Day 6
Day 7

Diastolic

Comments

